Only 10% of the plastic we manufacture gets recycled. For a century, we have relied on mechanical and chemical methods that were never designed to close the loop. As a product leader, I look for step-change technologies that break through entrenched ceilings, and biology—specifically engineered enzymes—has emerged as that missing piece.
Recently, I dug into the work of Rhea's Factory and spoke with their founders, Arzu Sandıkçı (co-founder and CEO) and Mert Topcu (co-founder). Arzu brings deep expertise in molecular biology and enzyme engineering. Mert brings 20 years in tech, including a decade at Google as a product manager. Their combined perspective—domain science plus product rigor—shows up in every design choice.
Rhea's Factory has built an AI platform that uses protein language models, multi-step agentic pipelines, and proprietary wet lab data to design novel enzymes that deconstruct plastic polymers into their original monomers—selectively, at low temperatures, and at industrial scale. That stack matters: it layers foundation models with domain-specific constraints and real-world data to systematically explore, evaluate, and scale candidates.
Here’s the crux: traditional recycling mostly just chops polymer chains into shorter fragments. Enzymatic recycling, by contrast, breaks plastic all the way back to its original monomers. Think of a necklace and pearls analogy—mechanical methods snip the chain; enzymes cleanly return the pearls. The result is true circularity: you can remake high-quality plastic without downcycling.
Selectivity is the superpower. Enzymes can target specific plastic types even in mixed waste streams, operating at low temperatures in a controlled, low energy reactor process. That combination of precision and energy efficiency is why this approach can be both greener and economically competitive.
The field accelerated after the discovery of a plastic-eating bacteria in Japan, which opened the door to enzymatic recycling. Advances in protein structure prediction—“AlphaFold” and the Nobel Prize in Chemistry—transformed what’s possible in enzyme engineering, and created space for AI-native design loops to flourish.
On the AI side, the team evolved from a human-orchestrated pipeline to an agentic AI scientist. Problem statements serve as inputs, multi-step protein generation builds on foundation models, and guardrails at each pipeline step keep the AI pointed in the right direction without limiting exploration. It’s a textbook example of agentic AI applied to a highly constrained, safety-critical domain.
Crucially, wet lab feedback closes the loop. Why wet lab data—even just hundreds of proprietary data points—can be enough to train a powerful domain-specific prediction model is a reminder that quality and relevance can trump sheer volume when you’re operating in a narrow, high-signal domain. The team measures success in the lab first, then scales what works.
I appreciated their take on exploration: there are moments when Mert sometimes wants the model to hallucinate. Running high temperature settings helps explore the full enzyme design space, and the guardrails ensure those forays remain productive rather than random. In other words, controlled creativity beats blind search.
The business constraint is unambiguous: enzymatic recycling must compete economically with cheap, oil-based plastic production. That framing forces disciplined choices around energy use, throughput, and yield—factors that directly determine unit economics and the path to industrial reality and cost parity.
What’s next is equally compelling: a process agent to optimize end-to-end system performance, a 5,000-ton demo plant in California to validate scale, and enzymes for new plastic types. I’m especially intrigued by enzyme blends for mixed plastics and the practical insight into why clamshells aren’t recyclable—precisely the messy corner cases that decide whether circularity works outside the lab.
From a product management lens, several patterns stand out: define clear problem statements as inputs to the agentic orchestration; use eval-driven development to enforce stage-by-stage quality; build a proprietary data moat with wet lab results; and tie milestones to industrial metrics (conversion, selectivity, energy per ton) rather than vanity outputs. This is AI Strategy in action—aligning model capability, data leverage, and operational design to deliver outcomes, not just demos.
Most of all, the ambition to explore an enzyme design space that “makes everything nature has ever evolved look like a tiny dot” captures the promise of this approach. Pairing agentic AI with rigorous lab validation doesn’t just make plastic circularity plausible—it makes it programmable.
Inspired by this post on Product Talk.
Leave a Reply